Skip to content
ARCL Organics logo

ARCL Organics

ARCL NSE
₹207.03 −4.97 (−2.34%)
P/E
16.05
View as Markdown
MCP
Close 4 Nov 2026 ₹207.03 −116.77 −36.1% 1Y
Start ₹323.80

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
17.00%
Debt to Equity
0.87
EPS (TTM)
₹12.90
Book Value
₹102.76
Market Cap
—
P/E (TTM)
16.05
P/B
2.01
ROE
6.93%
Dividend Yield
0.00%
EBITDA
₹28.60 Cr
52W High
₹434.60
52W Low
₹150.00
Day Range
₹200.00 – ₹218.00
Volume
648

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

51 Average

Data confidence 100/100

Category scores

Quality
54
Average
Returns, margins, earnings quality 22% weight
Valuation
44
Weak
Cheap vs sector & own history 24% weight
Growth
42
Weak
Sales & profit trajectory 9% weight
Financial Health
38
Weak
Solvency, leverage, coverage 9% weight
Momentum
63
Good
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

No strengths listed

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 13.8% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1252
OscillatorsNeutral252
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
37.63
Neutral
MACD (12,26,9)
−6.96
Bearish
SMA (50)
232.91
Bearish
SMA (200)
207.42
Bearish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
5Y+25.61%
3Y+18.13%
1Y+8.37%
TTM+5.40%

Net profit

Net profit growth by window
5Y−8.97%
3Y−25.31%
1Y−58.33%
TTM−23.89%

Operating cash flow

Operating cash flow growth by window
5YTurned negative
3YTurned negative
1YTurned negative
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
5Y−4.60 pp
3Y−1.72 pp
1Y−0.37 pp
TTM+2.94 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2019₹71.00 Cr
Mar 2020₹71.00 Cr
Mar 2021₹87.00 Cr
Mar 2022₹141 Cr
Mar 2023₹165 Cr
Mar 2024₹191 Cr
Mar 2025₹251 Cr
Mar 2026₹272 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2019₹1.00 Cr
Mar 2020₹3.00 Cr
Mar 2021₹8.00 Cr
Mar 2022₹11.00 Cr
Mar 2023₹12.00 Cr
Mar 2024₹11.00 Cr
Mar 2025₹12.00 Cr
Mar 2026₹5.00 Cr

Quarterly Results

₹ Cr
543993 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
41.58
43.25
48.33
57.57
59.93
56.46
61.96
72.24
67.34
86.19
53.47
65.31
66.95
Expenses
38.42
39.51
41.2
52.27
54.14
51.19
58.14
63.29
60.87
74.77
53.79
58.22
51.32
Operating Profit
3.16
3.74
7.13
5.3
5.79
5.27
3.82
8.95
6.47
11.42
−0.32
7.09
15.63
OPM %
7.6%
8.65%
14.75%
9.21%
9.66%
9.33%
6.17%
12.39%
9.61%
13.25%
−0.6%
10.86%
23.35%
Other Income
0.43
0.64
0.81
0.82
0.41
0.71
0.83
0.4
0.83
1.18
0.59
0.78
0.93
Interest
0.51
0.69
1.39
0.48
1.08
1.08
0.98
1.07
0.99
0.84
1.38
1.75
1.75
Depreciation
1.33
1.29
1.17
0.5
1.37
1.13
1.29
1.42
1.39
1.49
1.51
1.63
1.9
PBT
1.75
2.4
5.38
5.14
3.75
3.77
2.38
6.86
4.92
10.27
−2.62
4.49
12.91
Tax %
−12%
47.92%
29.37%
1.95%
26.13%
42.44%
24.37%
18.51%
18.7%
29.7%
236.26%
37.86%
29.36%
Net Profit
1.96
1.25
3.8
5.04
2.77
2.18
1.79
5.6
3.99
7.22
−8.81
2.79
9.12
EPS (₹)
2.45
1.56
4.75
6.3
3.46
2.72
2.24
7
4.99
9.02
−11.01
3.49
11.4

Profit & Loss

₹ Cr
543993 profit and loss, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
71
71
87
141
165
191
251
272
272
Expenses
67
64
74
126
147
171
227
248
238
Operating Profit
4
7
12
15
18
19
24
25
34
OPM %
6%
9%
14%
11%
11%
10%
10%
9%
12%
Other Income
1
1
2
2
3
3
2
3
3
Interest
2
3
2
1
2
3
4
5
6
Depreciation
1
1
1
1
3
4
5
6
7
PBT
1
3
11
15
17
15
17
17
25
Tax %
26%
24%
28%
29%
30%
23%
26%
70%
—
Net Profit
1
3
8
11
12
11
12
5
10
EPS (₹)
1.39
3.15
10.05
13.16
14.59
14.12
15.41
6.49
12.9
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
543993 balance sheet, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
8
8
8
8
8
8
8
8
Reserves
14
16
24
35
46
58
69
74
Borrowings
20
17
9
15
20
29
34
71
Other Liabilities
15
13
27
41
46
63
57
67
Total Liabilities
57
55
68
98
120
157
169
220
Fixed Assets
22
21
20
27
46
63
68
97
CWIP
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
Other Assets
35
34
48
71
74
94
101
123
Total Assets
57
55
68
98
120
157
169
220

Cash Flow

₹ Cr
543993 cash flow, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
−2
6
6
2
25
13
5
−4
Investing
−4
0
−1
−7
−22
−21
−9
−34
Financing
7
−5
−4
5
4
7
2
32
Net Cash Flow
0
0
1
−1
7
−1
−2
−5
Free Cash Flow
−7
5
5
−6
3
−8
−5
−39
CFO/EBITDA
−55
90
60
26
152
66
22
−7

Ratios

543993 financial ratios, annual
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
87
87
96
82
71
66
75
56
Inventory Days
35
45
40
43
38
58
28
45
Days Payable
51
43
89
88
105
130
90
79
Cash Conversion Cycle
71
89
48
37
4
−6
14
22
Working Capital Days
2
32
48
41
16
19
21
2
ROCE %
—
15%
32%
33%
28%
21%
20%
17%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view ARCL Organics insights

63 extracted metrics across FY19–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 69.22%
  • Others 16.77%
  • Public 13.27%
  • DIIs 0.75%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about ARCL Organics

What does ARCL Organics Ltd do?
Incorporated in 1992, ARCL Organics Ltd manufactures and sells chemical-based products Hardeners, and specialized One-Shot Resins
Where is ARCL Organics Ltd (ARCL) listed?
ARCL Organics Ltd trades as ARCL on the NSE and under code 543993 on the BSE.
Which sector does ARCL Organics Ltd belong to?
ARCL Organics Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the PE ratio of ARCL Organics Ltd?
ARCL Organics Ltd trades at a PE ratio of 16.05 as of 4 Nov 2026, on earnings per share of ₹12.9, against a book value of ₹102.76 per share.
What is the 52-week high and low of ARCL Organics Ltd?
Over the last 52 weeks ARCL Organics Ltd has traded between ₹150 and ₹434.6 as of 4 Nov 2026.
What is the Return on Equity (ROE) of ARCL Organics Ltd?
ARCL Organics Ltd reported a return on equity of 6.93%. Its debt-to-equity ratio is 0.87.

Company Information

Incorporated in 1992, ARCL Organics Ltd manufactures and sells chemical-based products Hardeners, and specialized One-Shot Resins

Website arclorganics.com
Listed 29 Sep 2023
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543993.md for ARCL Organics Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month